Naproxen/Omeprazole
萘普生/奥美拉唑
Report date: 2022/11/25 17:42:31
Base Information
Drug NameNaproxen/Omeprazole
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsYes NaproxenOmeprazole
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAralez Pharma
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesAutobahn Therapeutics Inc
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A